Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.5488
+0.0187 (3.53%)
At close: Jul 9, 2025, 4:00 PM
0.4760
-0.0728 (-13.27%)
Pre-market: Jul 10, 2025, 7:40 AM EDT
Entero Therapeutics Market Cap
Entero Therapeutics has a market cap or net worth of $2.62 million as of July 10, 2025. Its market cap has decreased by -48.72% in one year.
Market Cap
2.62M
Enterprise Value
3.39M
1-Year Change
-48.72%
Ranking
Category
Stock Price
0.55
Market Cap Chart
Since October 11, 2016, Entero Therapeutics's market cap has decreased from $49.20M to $2.62M, a decrease of -94.68%. That is a compound annual growth rate of -28.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2025 | 2.50M | -16.67% |
| Dec 31, 2024 | 3.00M | 7.14% |
| Dec 29, 2023 | 2.80M | -45.10% |
| Dec 30, 2022 | 5.10M | -71.67% |
| Dec 31, 2021 | 18.00M | -38.98% |
| Dec 31, 2020 | 29.50M | 8.46% |
| Dec 31, 2019 | 27.20M | 32.68% |
| Dec 31, 2018 | 20.50M | -51.19% |
| Dec 29, 2017 | 42.00M | -7.89% |
| Dec 30, 2016 | 45.60M | -7.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |